Eric S. Daar
- Virology top 0.02%
- HIV Research and Treatment 144
- Infectious Diseases top 0.05%
- HIV/AIDS Research and Interventions 125
- HIV/AIDS drug development and treatment 109
- Emergency Medicine top 0.1%
- HIV-related health complications and treatments 55
- Hepatology top 1%
- Hepatitis C virus research 16
- Epidemiology top 0.5%
- HIV, Drug Use, Sexual Risk 24
- Cytomegalovirus and herpesvirus research 14
-
- Immune Cell Function and Interaction 18
- Co-authors
- David D. HoTarsem MoudgilSusan J. LittleRichard D. MeyerDouglas D. RichmanPaul E. SaxAnn C. CollierCamlin Tierney
- Journals
- JAIDS Journal of Acquired Immune Deficiency Syndromes (24 papers)The Journal of Infectious Diseases (20 papers)AIDS (17 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Eric S. Daar
228 papers receiving 11.2k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Virology 7.2k
- Infectious Diseases 7.3k
- Emergency Medicine 2.5k
- Hepatology 756
- Epidemiology 2.9k
Countries citing papers authored by Eric S. Daar
This map shows the geographic impact of Eric S. Daar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric S. Daar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric S. Daar more than expected).
Fields of papers citing papers by Eric S. Daar
This network shows the impact of papers produced by Eric S. Daar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric S. Daar. The network helps show where Eric S. Daar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eric S. Daar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 5 | |
| 3 | 2023 | 2 | |
| 4 | 2022 | 5 | |
| 5 | 2022 | 7 | |
| 6 | 2021 | 13 | |
| 7 | Symptom outcome measures for outpatient COVID-19 phase 3 treatment trials | 2021 | 0 |
| 8 | 2019 | 10 | |
| 9 | 2015 | 22 | |
| 10 | Changes in proteinuria and albuminuria with initiation of antiretroviral therapy: data from a randomized trial comparing tenofovir disoproxil fumarate/emtricitabine versus abacavir/lamivudine | 2014 | 1 |
| 11 | 2014 | 2 | |
| 12 | 2013 | 63 | |
| 13 | 2012 | 10 | |
| 14 | 2011 | 34 | |
| 15 | 2010 | 22 | |
| 16 | 2005 | 44 | |
| 17 | An individual-based epidemiological model for the transmission of drug resistant HIV | 2002 | 2 |
| 18 | 2000 | 355 | |
| 19 | Recombinant Human Growth Hormone in Patients with HIV-Associated Wasting | 1996 | 74 |
| 20 | 1994 | 28 |
About Eric S. Daar
Eric S. Daar is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 239 papers that have together received 11.5k indexed citations. Recurring topics across this work include HIV Research and Treatment (144 papers), HIV/AIDS Research and Interventions (125 papers), HIV/AIDS drug development and treatment (109 papers), HIV-related health complications and treatments (55 papers), HIV, Drug Use, Sexual Risk (24 papers), Immune Cell Function and Interaction (18 papers), Hepatitis C virus research (16 papers) and Cytomegalovirus and herpesvirus research (14 papers). The work is most often cited by research in Virology (7.2k citations), Infectious Diseases (7.3k citations) and Emergency Medicine (2.5k citations). Eric S. Daar has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include David D. Ho, Tarsem Moudgil, Susan J. Little, Richard D. Meyer, Douglas D. Richman, Paul E. Sax, Ann C. Collier, Camlin Tierney, Nicholas S. Hellmann and Nasreen C. Jahed. Their work appears in journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes, The Journal of Infectious Diseases, AIDS, Clinical Infectious Diseases and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.